Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
HELP
HELP
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
HELP News
BetterLife Appoints Doug Drysdale as Executive Chairman
May 13 2026
Yahoo Finance
Helus Pharma Partners with TARA Mind to Advance Veteran Mental Health
Apr 30 2026
Newsfilter
Helus Pharma CEO to Speak at Health Innovation Forum
Apr 30 2026
Newsfilter
Helus Pharma Partners with TARA Mind to Advance Clinical Trial Recruitment
Apr 28 2026
Newsfilter
FDA Accelerates Development of Psychedelic Treatments for Mental Health
Apr 24 2026
stocktwits
Helus Pharma Expands Scientific Advisory Board with Industry Leaders
Apr 23 2026
Newsfilter
Trump Signs Executive Order to Accelerate Psychedelic Research
Apr 20 2026
CNBC
White House Psychedelics Executive Order Accelerates Research
Apr 20 2026
Newsfilter
Helus Pharma CEO Michael Colais Steps Down Immediately
Apr 20 2026
seekingalpha
Helus Pharma Welcomes White House Executive Order on Psychedelic Treatments
Apr 20 2026
Newsfilter
Helus Pharma Announces Transition in Leadership; Eric So to Take on Interim CEO Role
Apr 20 2026
moomoo
Trump Signs Executive Order to Accelerate Psychedelic Drug Reviews
Apr 20 2026
Newsfilter
Trump Administration to Examine Safety of Psychedelic Drug for PTSD
Apr 18 2026
Yahoo Finance
Helus Pharma Appoints New SVP of Medical Affairs
Apr 16 2026
Newsfilter
Helus Pharma Advances New Drug for Anxiety Treatment
Mar 09 2026
Newsfilter
Helus Pharma Advances Mental Health Treatments with Promising Phase 2 Results
Mar 09 2026
PRnewswire
Show More News
